SPONSOR
Pulnovo Medical (Wuxi) Co., Ltd.
Total Trials
2
Recruiting
2
Phases
Phase 3
Conditions studied: Pulmonary HypertensionHeart Failure With Reduced Ejection FractionHypertensionVascular DiseasesCardiovascular DiseasesHeart FailureHeart Failure With Preserved Ejection FractionHeart Failure With Mid Range Ejection FractionHypertension, Pulmonary Arterial
Pulnovo Medical (Wuxi) Co., Ltd. is a clinical research sponsor with 2 registered studies on ClinicalTrials.gov, of which 2 are actively recruiting participants. Research covers conditions including Pulmonary Hypertension, Heart Failure With Reduced Ejection Fraction, Hypertension, Vascular Diseases.
The trial portfolio spans Phase 3 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — Pulnovo Medical (Wuxi) Co., Ltd.
How many clinical trials has Pulnovo Medical (Wuxi) Co., Ltd. sponsored?
ClinicalMetric currently tracks 2 clinical trials sponsored by Pulnovo Medical (Wuxi) Co., Ltd., of which 2 are actively recruiting participants. These trials cover conditions including Pulmonary Hypertension, Heart Failure With Reduced Ejection Fraction, Hypertension. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does Pulnovo Medical (Wuxi) Co., Ltd. research focus on?
Pulnovo Medical (Wuxi) Co., Ltd. clinical trials span Pulmonary Hypertension, Heart Failure With Reduced Ejection Fraction, Hypertension, Vascular Diseases, Cardiovascular Diseases, and additional conditions. The research pipeline includes Phase 3 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a Pulnovo Medical (Wuxi) Co., Ltd. clinical trial?
To participate in a Pulnovo Medical (Wuxi) Co., Ltd. trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Pulnovo Medical (Wuxi) Co., Ltd. trials with current recruitment status updated daily.
Clinical Trials by Pulnovo Medical (Wuxi) Co., Ltd.
NCT05824923 Phase 3
Recruiting
A Trial to Evaluate the Safety and Efficacy of Pulmonary Artery Denervation for the Treatment of Pulmonary Hypertension Associated With Left Heart Failure
Pulmonary Hypertension
NCT07039604
Recruiting
Real-World Study of PADN for the Treatment of PAH
Pulmonary Hypertension
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology